DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · IEX Real-Time Price · USD
2.800
-0.150 (-5.08%)
At close: Jul 2, 2024, 4:00 PM
2.801
+0.001 (0.04%)
After-hours: Jul 2, 2024, 7:38 PM EDT
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $106.30 million as of July 2, 2024. Its market cap has decreased by -7.16% in one year.
Market Cap
106.30M
Enterprise Value
60.16M
1-Year Change
-7.16%
Ranking
Category
Stock Price
$2.80
Market Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $106.30M, an increase of 189.64%. That is a compound annual growth rate of 21.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 112.00M | 3.90% |
| Dec 29, 2023 | 107.80M | 157.89% |
| Dec 30, 2022 | 41.80M | -57.61% |
| Dec 31, 2021 | 98.60M | -48.11% |
| Dec 31, 2020 | 190.00M | 226.46% |
| Dec 31, 2019 | 58.20M | 68.70% |
| Dec 31, 2018 | 34.50M | -5.99% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Assertio Holdings | 109.39M |
| PDS Biotechnology | 108.20M |
| Akoya Biosciences | 107.66M |
| LakeShore Biopharma Co | 107.27M |
| Seer, Inc. | 106.50M |
| Seres Therapeutics | 106.17M |
| So-Young International | 105.94M |
| aTyr Pharma | 104.90M |